A controlled trial of anti-tumor necrosis factor alpha antibody for Crohn's disease.
Sandborn
W J
WJ
D000906:Antibodies / Q000627:therapeutic use*; D003424:Crohn Disease / Q000503:physiopathology / Q000628:therapy*; D004311:Double-Blind Method; D006801:Humans; D007167:Immunotherapy; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000906:Antibodies; D014409:Tumor Necrosis Factor-alpha